Navigation For Mobile

Archives

Blockbuster Drugs Hang On: Is a Post-Blockbuster World in Sight Yet?

“Blockbuster” drugs — typically defined as those that generate annual sales of $1 billion or more — have been the lifeblood of Big Pharma company revenues since Smith, Kline and French’s…

Posted in blockbuster, drugs | Tagged , , , | Comments Off on Blockbuster Drugs Hang On: Is a Post-Blockbuster World in Sight Yet?

Generic Drug Opportunities in Global Markets

Generic drugs have moved quickly over the last 30 years into a position of dominance in drug markets around the world. In 2018, generic drug savings totaled $293 billion in…

Posted in APIs, drugs, generic | Tagged , , | Comments Off on Generic Drug Opportunities in Global Markets

The Dizzying Confusion of Drug Pricing Regulations

In 2019, drug pricing was expected to be a top drug industry issue heading into the New Year. Things changed in 2020. The pharma industry (and the whole world) was…well…slightly…

Posted in drugs, generic, Industry news, supply chain | Tagged , , | Comments Off on The Dizzying Confusion of Drug Pricing Regulations